Lamisil and Rezulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamisil (terbinafine hydrochloride) and Rezulin (troglitazone). Common drug interactions include diarrhoea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lamisil and Rezulin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Rezulin?

Rezulin has active ingredients of troglitazone. eHealthMe is studying from 8,764 Rezulin users. Check the latest studies of Rezulin.

On Jul, 11, 2026

18 people who take Lamisil and Rezulin together, and have interactions are studied.

What are the common drug interactions of Lamisil and Rezulin, by gender? *:

female:

Diarrhoea
Bradycardia (abnormally slow heart action)
Cardiac failure
Cardiac failure congestive
Coma (state of unconsciousness lasting more than six hours)
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Dyspnoea (difficult or laboured respiration)
Fluid retention (an abnormal accumulation of fluid in the blood)
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)

male:

Chronic kidney disease
Diabetic end stage renal disease
Obesity (having too much body fat)
Obstructive airways disorder (a progressive disease that makes it hard to breathe)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Type 2 diabetes mellitus
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Cardiac failure congestive
Chronic fatigue syndrome (disorder that causes extreme fatigue)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the common drug interactions of Lamisil and Rezulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Drug effect decreased

10-19:

n/a

20-29:

n/a

30-39:

Extrasystoles
Fatigue (feeling of tiredness)
Oedema peripheral (superficial swelling)

40-49:

Breast lump (localized swelling that feels different from the surrounding breast tissue)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Cough
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diabetes mellitus inadequate control
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Diarrhoea
Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Mitral valve incompetence (inefficient heart valve)
Nasopharyngitis (inflammation of the nasopharynx)

50-59:

Chronic kidney disease
Diabetic end stage renal disease
Drug ineffective
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Cardiac failure congestive
Chronic fatigue syndrome (disorder that causes extreme fatigue)
Dyspnoea (difficult or laboured respiration)

60+:

Weight increased
Bradycardia (abnormally slow heart action)
Nausea (feeling of having an urge to vomit)
Renal failure acute (rapid kidney dysfunction)
Sudden death unexplained
Acute pre-renal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrophy (wasting away of a part of the body)
Blood magnesium decreased

What are the existing conditions these people have? *

Swelling: 4 people, 22.22%
Pain: 4 people, 22.22%
Neuropathy Peripheral (surface nerve damage): 4 people, 22.22%
Kidney Stones: 4 people, 22.22%
Inflammation: 4 people, 22.22%
Hypersensitivity: 4 people, 22.22%
High Blood Pressure: 4 people, 22.22%
High Blood Cholesterol: 4 people, 22.22%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
Diabetes: 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and Rezulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously